| Alterations in p53 predict response to preoperative high dose chemotherapy in patients with gastric cancer | |||||||||||||
Abstract | |||||||||||||
| Aims: To evaluate the usefulness of molecular markers in predicting histopathological and clinical response to preoperative high dose chemotherapy (HDCT) and survival of patients with advanced gastric cancer. | |||||||||||||
Details der Publikation | |||||||||||||
| |||||||||||||